Sanger Leadership Team
The Sanger Leadership Team is an Executive Committee that reports to the Director and the Genome Research Limited (GRL) Board. It is designed to enable holistic and effective decision making, with transparency and accountability woven into its make up. The Committee is made up of senior leaders that are tasked with making significant and sound decisions in the best interest of Sanger as it supports and delivers its scientific mission and positively influences Sanger’s organisational culture with a focus on equality, diversity and inclusion.
Membership
Secretariat
Executive Assistant to Wellcome Sanger Institute Director
Katharine Sparrow
Members
Deputy Chair
Director of Strategy, Policy and Innovation
Chief Operating Officer
Dr Simon Moore
Interim Director of Connecting Science
Interim Head of the Cancer, Ageing and Somatic Mutation Programme
Interim Head of the Cellular Genetics Programme
Head of the Generative and Synthetic Genomics Programme
Interim Head of the Human Genetics Programme
Head of the Parasites and Microbes Programme
Head of the Tree of Life Programme
Director of Scientific Operations
Interim Chief Finance Officer
Spencer Evans
Director of Human Resources
Chief Information Officer
General Counsel and Company Secretary
Standing Attendees
Standing attendees do not have a vote but their input is critical in informing decisions and help bring a wider perspective.
Employee Partnership Co-Chair
Tom Preston
Chief of Staff to Sanger Director
Head of Corporate Governance
Carys Stedman-Lloyd
Observers
Wellcome Representative
Matt Kaiser